Skip to content

A Human Application Study to Evaluate the Suitability of CureCode Soothing Relief Cleanser for Acne-Prone Skin

A Human Application Study on the Suitability for Non-Comedogenicity of “CureCode Soothing Relief Cleanser”

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0012097
Enrollment
22
Registered
2026-06-09
Start date
2024-12-09
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(COSMETICS) : The test product was CureCode Soothing Relief Cleanser. In this study, the test product site, untreated negative control site, and positive control site treated with a comedogenic

Sponsors

Dr. Raymond Lab Inc
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults aged 20 to 40 years 2. Subjects with a facial Global Acne Grading System (GAGS) score of 1 to 30 3. Subjects who understood the purpose and content of the study and voluntarily signed the informed consent form 4. Subjects without acute or chronic physical diseases, including skin diseases 5. Subjects who were able to comply with follow-up visits during the study period

Exclusion criteria

Exclusion criteria: 1. Subjects who did not wish to participate or did not sign the informed consent form 2. Subjects who were pregnant, lactating, or planning pregnancy within 6 months 3. Subjects who had used topical steroid-containing preparations for the treatment of skin diseases for more than 1 month 4. Subjects with sensitive or hypersensitive skin 5. Subjects with abnormal skin findings at the test site, such as moles, acne, erythema, or telangiectasia 6. Subjects who had used products with the same or similar efficacy on the test site within 3 months before the study 7. Subjects who had undergone procedures on the test site within 6 months before the study 8. Subjects with mental illness or intellectual disability 9. Subjects judged by the investigator or study staff to be unsuitable for participation in the study for any other reason

Design outcomes

Primary

MeasureTime frame
Change in follicular/comedone ratio before and after application

Secondary

MeasureTime frame
Assessment of adverse skin reactions

Countries

Korea, Republic of

Contacts

Public ContactMINYOUL CHANG

SKINMED

mychang195@gmail.com+82-42-5119-8437

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jun 21, 2026